Welcome to the 91st edition of the Research Digest. In our final edition for the year, a study evaluating aspects of the current IOM criteria is presented, as well as national and international research findings concerning Long Covid. The final edition also puts a spotlight on the disbelief that people living with invisible disabilities like ME/CFS and Long Covid endure, and highlights Anne Wilson’s call for the government to better recognise those living with invisible disabilities. Read more
This year, Emerge Australia's Annual General Meeting (AGM) will be held virtually on Thursday 1 December, 2022. Financial members can register to attend. Read more
UK Times article on how the focus Long COVID is bringing to post-viral fatigue conditions could transform the lives of all those living with them. Read more
Emerge Australia is pleased to have launched the latest element of our awareness campaign with a full-page advert in the Australian Financial Review to give ME/CFS a voice in the national Long COVID conversation. Read more
Win a signed 2022 Wests Tigers Jersey thanks to our friends at Wests Tigers! To go into the draw to win this great prize, donate today to our Christmas Telehealth Appeal, to help us support those with ME/CFS and Long COVID. A donation of as little as $25 helps someone in need. Read more
In 2023, the Australian ME/CFS Biobank and Registry will expand to collect vital data and biosamples from patients who are experiencing symptoms of long-COVID. Read more
Welcome to the 90th edition of the Research Digest. This month's edition features ME/CFS studies investigating microclotting and antibody targeting of gut bacteria. Also presented, is the study of serum samples from post-covid syndrome and -/+ME/CFS patients, to further study endothelial dysfunction and the role of angiogenesis in both study groups. And finally, the recent ABC news article featuring Chris Armstrong and Anne Wilson is highlighted. Read more
It is estimated 25% of individuals living with ME/CFS have severe or very severe symptoms. Ricky Buchanan worked with Emerge Australia to create some tips and hacks for those living with severe ME/CFS. Read more
Emerge Australia strongly advocates for the Federal Department of Health to make post-infection disease Australia’s 10th National Health Priority Area (NHPA). The number of Australians living with post-infection disease is rapidly increasing, predicted to be over half a million by the end of 2022, due to a new cohort of post-infection disease patients: those with Long COVID. Read more
Help more ME/CFS patients connect to Emerge Australia this Christmas. Delayed by misdiagnosis, people with ME/CFS and Long COVID are waiting too long for the vital support they need. Donate to Emerge Australia by through Christmas, so no one with ME/CFS or Long COVID misses out on help this Christmas. Read more
ME/CFS is a permanent condition for most people. Less than 10% recover to pre-illness functioning and 20% of patients may worsen with time.[1] Despite this, many people with ME/CFS experience significant difficulties accessing the National Disability Insurance Scheme (NDIS). Read more
A national, Optimal Care Referral Pathway (OCRP) will provide all people with ME/CFS consistent care across Australia, using an evidence-based, best practice pathway that empowers patients and clinicians to navigate support of complex, multi-system conditions such as ME/CFS, and other post infection diseases, such as Long COVID. Read more